ECSCR functions as a potential tumor suppressor in breast cancer cells
Sen Lian, Yi Huang, Ling Liang, Yiping Yang, Yingxi Mo, Shan Wang, Changyuan Wei · 2025
Read ECSCR functions as a potential tumor suppressor in breast cancer cells by Sen Lian, Yi Huang, Ling Liang, Yiping Yang, Yingxi Mo, Shan Wang, Changyuan Wei (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743086.txt.
Description
Sen Lian and co-authors test a gene that may brake breast cancer, in a 2025 study. The gene, ECSCR, surfaced when the team treated two breast cancer cell lines with resveratrol, a plant compound with anti-cancer fame. In the hard triple-negative line, the drug switched the gene on strongly; in a hormone-sensitive line, it did not. Little was known of the gene's role in this cancer.
Forcing the gene on in breast cancer cells slowed their growth and spread and pushed them toward self-destruction. In animals, boosted cells formed weaker tumors. The team reads ECSCR as a tumor suppressor worth chasing, above all for the triple-negative kind that lacks targeted drugs.
Catalog record
| CREATOR | Sen Lian, Yi Huang, Ling Liang, Yiping Yang, Yingxi Mo, Shan Wang, Changyuan Wei |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |